Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,420 | 12,823 | 14,572 | 11,570 | 25,436 |
| Marketable Securities | 50,769 | 58,455 | 58,816 | 58,877 | 49,406 |
| TOTAL | $65,180 | $72,035 | $74,169 | $71,359 | $76,053 |
| Non-Current Assets | |||||
| PPE Net | 925 | 949 | 1,011 | 1,067 | 1,181 |
| Investments And Advances | 1,100 | 5,011 | 11,850 | 23,724 | 29,927 |
| Other Non-Current Assets | 160 | 160 | 164 | 169 | 175 |
| TOTAL | $2,185 | $6,120 | $13,025 | $24,960 | $31,283 |
| Total Assets | $67,365 | $78,155 | $87,194 | $96,319 | $107,336 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,294 | 675 | 615 | 1,028 | 809 |
| Accrued Expenses | 6,094 | 4,819 | 4,919 | 4,213 | 6,937 |
| TOTAL | $7,388 | $5,494 | $5,534 | $5,241 | $7,746 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 144 | 154 | 163 | 173 | 181 |
| TOTAL | $144 | $154 | $163 | $173 | $181 |
| Total Liabilities | $7,532 | $5,648 | $5,697 | $5,414 | $7,927 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,291 | 44,291 | 44,132 | 44,074 | 43,694 |
| Common Shares | 44 | 44 | 44 | 44 | 44 |
| Retained earnings | -282,339 | -267,096 | -255,522 | -243,875 | -231,797 |
| Other shareholders' equity | 0 | -56 | 28 | -5 | -8 |
| TOTAL | $59,833 | $72,507 | $81,497 | $90,905 | $99,409 |
| Total Liabilities And Equity | $67,365 | $78,155 | $87,194 | $96,319 | $107,336 |